Implementing a Statistical Model for Protamine Titration: Effects on Coagulation in Cardiac Surgical Patients

Area of Science:

• Cardiovascular Surgery
• Anesthesiology
• Pharmacology

Background:

• Protamine is used to neutralize heparin after cardiopulmonary bypass.
• Excessive protamine can lead to adverse effects, including hypotension and thrombocytopenia.
• Accurate protamine dosing is crucial for patient safety and effective heparin reversal.

Purpose of the Study:

• To implement and evaluate a statistical model for optimizing protamine titration in patients undergoing coronary artery bypass surgery.
• To compare the efficacy and safety of a statistically modeled protamine dose versus a fixed dose.

Main Methods:

• A prospective randomized trial was conducted with 60 patients undergoing elective coronary artery bypass surgery.
• Patients were assigned to receive protamine based on a statistical model algorithm or a fixed 1:1 protamine-heparin ratio.
• Coagulation parameters were assessed using rotational thromboelastometry.

Main Results:

• The statistical model significantly reduced the mean protamine dose from 426±43 mg to 251±66 mg (p<0.01).
• This resulted in significantly shorter intrinsic clotting time (208±29s vs. 244±52s) and stronger clot firmness (p=0.01).
• Residual heparin effects were comparable between groups, with no significant differences in heparinase-verified clotting time.

Conclusions:

• The statistical model for protamine titration is clinically feasible and effectively reduces protamine exposure.
• This approach demonstrates advantageous effects on coagulation as measured by rotational thromboelastometry.
• Further studies are needed to define the clinical outcome significance of this optimized protamine dosing strategy.